ACA
Avoro Capital Advisors Portfolio holdings
AUM
$5.71B
This Quarter Return
-15.55%
1 Year Return
+11.37%
3 Year Return
+255.37%
5 Year Return
+558.9%
10 Year Return
+18,722.72%
AUM
$2.4B
AUM Growth
+$2.4B
(-17%)
Cap. Flow
+$51.9M
Cap. Flow
% of AUM
2.16%
Top 10 Holdings %
Top 10 Hldgs %
69.51%
Holding
37
New
3
Increased
9
Reduced
7
Closed
3
Top Buys
| 1 |
Karyopharm Therapeutics
KPTI
|
$58.2M |
| 2 |
Pacira BioSciences
PCRX
|
$45.7M |
| 3 |
BioMarin Pharmaceuticals
BMRN
|
$21.7M |
| 4 |
Sarepta Therapeutics
SRPT
|
$20.9M |
| 5 |
ATNX
Athenex, Inc. Common Stock
ATNX
|
$15.6M |
Top Sells
| 1 |
ARRY
Array Biopharma Inc
ARRY
|
$92.7M |
| 2 |
MDCO
Medicines Co
MDCO
|
$27.7M |
| 3 |
Acadia Pharmaceuticals
ACAD
|
$15.7M |
| 4 |
Adaptive Biotechnologies
ADPT
|
$9.66M |
| 5 |
MRTX
Mirati Therapeutics, Inc. Common Stock
MRTX
|
$8.76M |
Sector Composition
| 1 | Healthcare | 87.61% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
uniQure
QURE
$933M
| $14.4M | 0.6% |
+365,000
| New | +$14.4M |
|
|
CBAY
27
DELISTED
Cymabay Therapeutics
CBAY
| $13.8M | 0.58% |
2,700,000
| – | – |
|
28
Kodiak Sciences
KOD
$478M
| $7.19M | 0.3% |
500,000
-77,021
| -13% | -$1.11M |
|
29
Fennec Pharmaceuticals
FENC
$247M
| $5.32M | 0.22% |
1,105,999
| – | – |
|
|
TLGT
30
DELISTED
Teligent, Inc
TLGT
| $4.97M | 0.21% |
5,231,206
| – | – |
|
|
TPTX
31
DELISTED
Turning Point Therapeutics, Inc. Common Stock
TPTX
| $3.76M | 0.16% |
+100,000
| New | +$3.76M |
|
|
ALIM
32
DELISTED
Alimera Sciences, Inc.
ALIM
| $3.53M | 0.15% |
6,240,000
| – | – |
|
33
Rocket Pharmaceuticals
RCKT
$354M
| $3.33M | 0.14% |
285,714
| – | – |
|
|
34
Adaptive Biotechnologies
ADPT
$2.01B
| – | – |
-200,000
| Closed | -$9.66M |
|
35
Indaptus Therapeutics
INDP
$6.81M
| – | – |
-820,000
| Closed | -$3.56M |
|
36
iShares Russell 2000 ETF
IWM
$66.6B
| – | – |
0
| – | – |
|
|
ARRY
37
DELISTED
Array Biopharma Inc
ARRY
| – | – |
-2,000,000
| Closed | -$92.7M |
|